Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies

Dysregulated cellular metabolism is a characteristic feature of malignancy that has been exploited for both imaging and targeted therapy. With regard to imaging, deranged glucose metabolism has been leveraged using (18)F-FDG PET. Metabolic imaging with (18)F-FDG, however, probes only the early steps...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantel, Austin R., Ackerman, Daniel, Lee, Seung-Cheol, Mankoff, David A., Gade, Terence P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2018
Materias:
The State of the Art
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126440/
https://www.ncbi.nlm.nih.gov/pubmed/30042161
http://dx.doi.org/10.2967/jnumed.117.199869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126440/
https://www.ncbi.nlm.nih.gov/pubmed/30042161
http://dx.doi.org/10.2967/jnumed.117.199869

Ejemplares similares